ANAscreen is an ELISA test system for the qualitative measurement of IgG antibodies against nuclear antigens, SS-A 52, SS-A 60, SS-B, RNP-70, Sm, RNP/Sm, Scl-70, Centromere B, and Jo-1, in human serum or plasma.

Antinuclear antibodies (ANA) are detected in patients with systemic autoimmune diseases such as systemic lupus erythematosus (SLE), Sjögren’s syndrome, Sharp syndrome, polymyositis/dermatomyositis, and progressive systemic scleroderma (PSS) with CREST syndrome. ANA thus partially act as makers for the individual connective tissue diseases. Each individual well of the ANAscreen test is coated with a mixture of nine human recombinant and native, highly purified antigens, allowing for sensitive detection of these autoantibodies. After a positive result with this test, further differentiation of the autoantibodies should be carried out with the ANAcombi test or the respective single antigen ELISA assays from ORGENTEC.


Product Number ORG 538
Tests12 x 8 tests
CalibrationCDC sera
Cut-offIndex > 1.2
Coating centromere B, histidyl-tRNA synthetase (Jo-1), RNP-70, RNP/Sm complex, Scl-70 protein (DNA topoisomerase I), Smith antigen (Sm), SS-A 52 (Ro 52), SS-A 60 (Ro 60), SS-B (La)

ORG 200   ORG 233   ORG 238   ORG 206   ORG 213   ORG 232   ORG 211   ORG 212   ORG 208   ORG 252   ORG 260   ORG 209  


ORG 539   ORG 600   ORG 633   ORG 506   ORG 513   ORG 514   ORG 546   ORG 632   ORG 511   ORG 544   ORG 512   ORG 508   ORG 652   ORG 660   ORG 509  


ORG 710   ORG 711   ORG 760  


Instruction for Use
Safety Data Sheet

Document Archive
Instruction for Use Revision 3. Earlier versions and additional languages can be found in the document archive.